These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Bacteria From Marine Sponges: A Source of New Drugs. Bibi F; Faheem M; Azhar EI; Yasir M; Alvi SA; Kamal MA; Ullah I; Naseer MI Curr Drug Metab; 2017; 18(1):11-15. PubMed ID: 27739371 [TBL] [Abstract][Full Text] [Related]
25. Bis and tris indole alkaloids from marine organisms: new leads for drug discovery. Gupta L; Talwar A; Chauhan PM Curr Med Chem; 2007; 14(16):1789-803. PubMed ID: 17627517 [TBL] [Abstract][Full Text] [Related]
26. Synthesis and bioactivity of secondary metabolites from marine sponges containing dibrominated indolic systems. Mollica A; Locatelli M; Stefanucci A; Pinnen F Molecules; 2012 May; 17(5):6083-99. PubMed ID: 22614862 [TBL] [Abstract][Full Text] [Related]
27. Metagenomic discovery of polybrominated diphenyl ether biosynthesis by marine sponges. Agarwal V; Blanton JM; Podell S; Taton A; Schorn MA; Busch J; Lin Z; Schmidt EW; Jensen PR; Paul VJ; Biggs JS; Golden JW; Allen EE; Moore BS Nat Chem Biol; 2017 May; 13(5):537-543. PubMed ID: 28319100 [TBL] [Abstract][Full Text] [Related]
28. Biosynthesis of Bioactive Natural Products Derived from Theonellidae Family Marine Sponges. Wakimoto T Chem Pharm Bull (Tokyo); 2023; 71(1):1-8. PubMed ID: 36596505 [TBL] [Abstract][Full Text] [Related]
29. Major Antimicrobial Representatives from Marine Sponges and/or Their Associated Bacteria. He F; Mai LH; Gardères J; Hussain A; Erakovic Haber V; Bourguet-Kondracki ML Prog Mol Subcell Biol; 2017; 55():35-89. PubMed ID: 28238035 [TBL] [Abstract][Full Text] [Related]
30. Secondary Metabolites from Marine-Derived Fungi from China. Liu Z; Frank M; Yu X; Yu H; Tran-Cong NM; Gao Y; Proksch P Prog Chem Org Nat Prod; 2020; 111():81-153. PubMed ID: 32114663 [TBL] [Abstract][Full Text] [Related]
31. Trends in the discovery of new marine natural products from invertebrates over the last two decades--where and what are we bioprospecting? Leal MC; Puga J; Serôdio J; Gomes NC; Calado R PLoS One; 2012; 7(1):e30580. PubMed ID: 22276216 [TBL] [Abstract][Full Text] [Related]
34. New marine natural products from sponges (Porifera) of the order Dictyoceratida (2001 to 2012); a promising source for drug discovery, exploration and future prospects. Mehbub MF; Perkins MV; Zhang W; Franco CMM Biotechnol Adv; 2016; 34(5):473-491. PubMed ID: 26802363 [TBL] [Abstract][Full Text] [Related]
35. Genome and metabolome mining of marine obligate Salinisporsatrains to discover new natural products. Özakin S; Ince E Turk J Biol; 2019; 43(1):28-36. PubMed ID: 30930633 [TBL] [Abstract][Full Text] [Related]
36. Isolation and diversity of natural product biosynthetic genes of cultivable bacteria associated with marine sponge Mycale sp. from the coast of Fujian, China. Su P; Wang DX; Ding SX; Zhao J Can J Microbiol; 2014 Apr; 60(4):217-25. PubMed ID: 24693980 [TBL] [Abstract][Full Text] [Related]
38. Marine Sponge-Associated Fungi as Potential Novel Bioactive Natural Product Sources for Drug Discovery: A Review. Zhang B; Zhang T; Xu J; Lu J; Qiu P; Wang T; Ding L Mini Rev Med Chem; 2020; 20(19):1966-2010. PubMed ID: 32851959 [TBL] [Abstract][Full Text] [Related]
39. The natural product biosynthetic potential of Red Sea nudibranch microbiomes. Abdelrahman SM; Patin NV; Hanora A; Aboseidah A; Desoky S; Desoky SG; Stewart FJ; Lopanik NB PeerJ; 2021; 9():e10525. PubMed ID: 33604161 [TBL] [Abstract][Full Text] [Related]
40. Metagenomic approaches to exploit the biotechnological potential of the microbial consortia of marine sponges. Kennedy J; Marchesi JR; Dobson AD Appl Microbiol Biotechnol; 2007 May; 75(1):11-20. PubMed ID: 17318533 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]